Ask an Eye M.D.Question Topics
Ask an Eye M.D. Answer Archive
Please read our important medical disclaimer.
Why was beta carotene omitted from Bausch & Lomb's AREDS-2 formulation?
The change in the AREDS formulation (nutritional supplements used to slow the progress of age-related macular degeneration, or AMD) results from the AREDS2 trial, where former smokers who took the formulation with beta-carotene had a higher incidence of lung cancer. This was not the case when taking the formulation with lutein/zeaxanthin. Also, participants who took a formulation with lutein/zeaxanthin and no beta-carotene had a slightly lower risk of progressing to advanced AMD when compared to those who took the previous formulation with beta-carotene and no lutein/zeaxanthin.
Answered by: Paul Sternberg Jr., MD
Categories: Eye Diseases
Have a question that hasn't been answered yet? Ask it!
Answered: Jul 28, 2014
Search for Questions & Answers
Meet Our Experts
- Your questions are answered by more than two dozen members of the American Academy of Ophthalmology who volunteer their time with EyeSmart.